Elevation Oncology, Inc.·4

Jun 18, 4:15 PM ET

Ferra Joseph J Jr 4

4 · Elevation Oncology, Inc. · Filed Jun 18, 2025

Insider Transaction Report

Form 4
Period: 2025-06-16
Ferra Joseph J Jr
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-06-16+12,560149,712 total
  • Tax Payment

    Common Stock

    2025-06-16$0.39/sh4,627$1,783145,085 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-06-1612,5600 total
    Common Stock (12,560 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]25% of the RSUs vested on June 16, 2022, and the remainder vested as to 1/16 of the total RSUs quarterly.
  • [F3]The RSUs do not expire; they either vest or are canceled prior to the vesting date.

Documents

1 file
  • 4
    form4-06182025_040601.xmlPrimary